5-Hydroxytryptamine [nsba, orch]
receptor [aapp, rcpt]
antagonists [chvf]
Cardiac [bpoc]
side effects [ftcn]
Introduction [hlca]
5-Hydroxytryptamine [nsba, orch]
receptor [aapp, rcpt]
antagonists [chvf]
HT3 [blor]
Ra [spco]
Antiemetics [phsu]
Oncology [bmod]
TOLERABILITY [resa]
QTC PROLONGATION [fndg]
Observed [ftcn]
Patients [podg]
Covered [ftcn]
Purpose [ftcn]
Article [inpr]
cardiac events [dsyn]
HT3 [blor]
RAS [gngm]
Focus [spco]
Ondansetron [orch, phsu]
Granisetron [orch, phsu]
palonosetron [orch, phsu]
Expert Opinion [cnce]
Electrocardiogram [fndg]
HT3 [blor]
Ra [spco]
Administration [ocac]
Healthy adult [fndg]
Young [tmco]
Patients [podg]
Postoperative Nausea and Vomiting [sosy]
Few [qnco]
Address [inpr]
Electrocardiogram [fndg]
Cancer Patient [podg]
treated [topp]
For [qlco]
Chemotherapy-induced nausea and vomiting [patf]
Investigations [hlca]
Cancer Patient [podg]
Essential [qlco]
Patients [podg]
Old [tmco]
Comorbidity [idcn]
included [ftcn]
Clinical Trials [resa]
Polypharmacy [fndg]
Drug drug interaction [moft]
Chemotherapy [topp]
QTC [qnco]
Drugs [phsu]
Pharmacokinetics [phsf]
pharmacodynamics [ftcn]
HT3 [blor]
RAS [gngm]
Cancer Patient [podg]
Expected [idcn]
Group [idcn]
Plus [qlco]
Old [tmco]
Address [inpr]
cardiac events [dsyn]
Cancer Patient [podg]
Known [qlco]
Heart disease [dsyn]
Receive [qlco]
Chemotherapy [topp]
HT3 [blor]
Ra [spco]
prophylaxis [inpr]
Of [spco]
Chemotherapy-induced nausea and vomiting [patf]
